Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor.
暂无分享,去创建一个
Jean Bennett | Rebecca Grant | T. Aleman | A. Cideciyan | S. Jacobson | J. Bennett | James M. Wilson | A. Maguire | A. Auricchio | R. Grant | Samuel G Jacobson | Tomas S Aleman | Artur V Cideciyan | Corinna Lebherz | James M Wilson | Alberto Auricchio | Albert M Maguire | Waixing Tang | Zhangyong Wei | W. Tang | C. Lebherz | Zhangyong Wei
[1] L. Yıldız,et al. Submacular surgery for choroidal neovascularization secondary to optic nerve drusen. , 2003, American journal of ophthalmology.
[2] R. Ali,et al. Gene therapy for ocular angiogenesis. , 2003, Clinical science.
[3] J. Bennett,et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. , 2003, Molecular vision.
[4] John I. Loewenstein,et al. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. , 2003, Ophthalmology.
[5] P. Rakoczy,et al. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy. , 2003, Diabetes.
[6] W. Manning,et al. AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. , 2003, Investigative ophthalmology & visual science.
[7] Yoshinori Mitamura,et al. Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. , 2002, Diabetes care.
[8] M. Matsumura,et al. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. , 2002, American journal of ophthalmology.
[9] P. Campochiaro,et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. , 2002, Investigative ophthalmology & visual science.
[10] T. Aleman,et al. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] G. Lutty,et al. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. , 2002, American journal of ophthalmology.
[12] R. Ali,et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1 , 2002, Gene Therapy.
[13] T. Cox,et al. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. , 2002, Experimental eye research.
[14] P. Campochiaro,et al. Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization , 2001, Journal of cellular physiology.
[15] R. Duvoisin,et al. Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model , 2001, Gene Therapy.
[16] N. McIntosh,et al. A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. , 2000, Investigative ophthalmology & visual science.
[17] K. Csaky,et al. Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. , 2000, Investigative ophthalmology & visual science.
[18] D. Hinton,et al. Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.
[19] T. Aleman,et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] Ivana K. Kim,et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. , 1999, Investigative ophthalmology & visual science.
[21] M. Mandai,et al. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model. , 1999, Investigative ophthalmology & visual science.
[22] I. Constable,et al. Generation and characterization of a recombinant adenovirus expressing vascular endothelial growth factor for studies of neovascularization in the eye. , 1999, Australian and New Zealand journal of ophthalmology.
[23] A. Cideciyan,et al. Relation of optical coherence tomography to microanatomy in normal and rd chickens. , 1998, Investigative ophthalmology & visual science.
[24] P. Campochiaro,et al. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. , 1998, Experimental eye research.
[25] P. Campochiaro,et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. , 1997, The American journal of pathology.
[26] S. Seregard,et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.
[27] G. Lutty,et al. Localization of vascular endothelial growth factor in human retina and choroid. , 1996, Archives of ophthalmology.
[28] E. Kohner,et al. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. , 1996, The British journal of ophthalmology.
[29] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[31] J. Penn,et al. Exposure to Alternating Hypoxia and Hyperoxia Causes Severe Proliferative Retinopathy in the Newborn Rat , 1994, Pediatric Research.
[32] Joan W. Miller,et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.
[33] T. Dryja,et al. Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa , 1992, Neuron.
[34] Matthew A. Thomas,et al. Surgical management of subfoveal choroidal neovascularization. , 1992, Ophthalmology.
[35] J. Fujimoto,et al. Optical Coherence Tomography , 1991, LEOS '92 Conference Proceedings.
[36] D. Ingber,et al. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. , 1991, Biochemical and biophysical research communications.
[37] C. Puliafito,et al. A new model of experimental choroidal neovascularization in the rat. , 1989, Archives of ophthalmology.
[38] R. Machemer,et al. Experimental subretinal hemorrhage in rabbits. , 1982, American journal of ophthalmology.
[39] James M. Wilson,et al. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. , 2001, Human gene therapy.
[40] R. Danis,et al. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531. , 1998, Investigative ophthalmology & visual science.
[41] E S Gragoudas,et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.
[42] J. Folkman,et al. Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .
[43] Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1991, Archives of ophthalmology.
[44] Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.
[45] N. Bressler,et al. Persistent and recurrent neovascularization after krypton laser kphotocoagualation for neovascular lesions fo age-related macular degenration , 1990 .
[46] Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group. , 1986, Archives of ophthalmology.